Shanghai, China | Fund Name | Location |
| Bankia | Community of Madrid, Madrid, Spain |
| BlueOrchard Finance S A | Geneva, Geneve, Switzerland |
| Clark Enterprises | Bethesda, Maryland, United States |
| E&Company | - |
| Emirates Islamic | Dubai, United Arab Emirates |
| Greylock Partners | California, Menlo Park, United States |
| InterVideo | California, Fremont, United States |
| KAIST Venture | - |
| Multi-Health Systems | Canada, Ontario, Toronto |
| N+1 Capital | Delhi, Delhi, India |
| National Health Forecast (PSN) | - |
| Questa Capital Management | California, San Francisco, United States |
| Synergy Energy | England, London, United Kingdom |
| Synergy Life Science Partner | California, Portola Valley, United States |
| Taylor Brothers | California, Los Angeles, United States |
| Upstart Life Ventures | Salt Lake City, United States, Utah |
| Wanxiang International Investment | China, Hangzhou, Zhejiang |
| WapInvest | - |
| Willett Advisors LLC | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ArrePath | $20M | 03 Mar 2022 | Princeton, New Jersey, United States | ||
| 09 Nov 2017 | Qingpu District, China | ||||
Haoyue | $463K | 28 Jul 2017 | China, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ArrePath | $20M | 03 Mar 2022 | Princeton, New Jersey, United States | ||
| 09 Nov 2017 | Qingpu District, China | ||||
Haoyue | $463K | 28 Jul 2017 | China, Zhejiang |
